Health HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial PRNW Agency Feb 13, 2023 Company to Utilize its New Edison™ System with Advanced Imaging Features for Use in Kidney Tumors MINNEAPOLIS, Feb. 13, 2023 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the developer of a non-invasive platform and novel sonic beam…